Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CombiMatrix President and CEO Dr. Amit Kumar Invited to Speak at the International Knowledge Millennium Summit in India; Presentation Will Focus on CombiMatrix's Efforts in Bird Flu Surveillance and Cancer Diagnostics.


NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG ACTG Acting
ACTG AIDS Clinical Trial Group
ACTG Actuating/Actuator
) announced today that Dr. Amit Kumar, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of CombiMatrix Corporation, will present an invited talk at the 4th Annual Knowledge Millennium Summit in India, on March 27th. This summit will focus on advances in biotechnology and nanotechnology, and includes participation from a group of international companies. This presentation will enable CombiMatrix to present its technology and products to the rapidly growing Indian and Asian Biotech and Nanotech communities as well as to participants from other countries.

Dr. Kumar's presentation will discuss CombiMatrix's technology for molecular diagnostics as well as for pathogen detection including analysis of samples of influenza.

More information about the summit can be found at www.assocham.org/nanobio/programme.doc.

ABOUT ACACIA RESEARCH CORPORATION

Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group.

The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.

The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 40 patent portfolios, which include over 150 U.S. patents, and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency co·her·en·cy  
n. pl. co·her·en·cies
Coherence.

Noun 1. coherency - the state of cohering or sticking together
coherence, cohesion, cohesiveness
, credit card fraud Credit card fraud is a wide-ranging term for theft and fraud committed using a credit card or any similar payment mechanism as a fraudulent source of funds in a transaction. The purpose may be to obtain goods without paying, or to obtain unauthorized funds from an account.  protection, database management, data encryption & product activation, digital media transmission (DMT See DSL. (R)), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, hearing aid ECS See eComStation. , image resolution enhancement, interactive data sharing, interactive television, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging, spreadsheet automation, user activated Internet advertising and web conferencing & collaboration software.

Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.

Information about the Acacia Technologies group and the CombiMatrix group is available at www.acaciaresearch.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 7, 2006
Words:538
Previous Article:INC Research Expands European Operations; Leading Contract Research Organization Opens New Offices in France, Russia and Ukraine.
Next Article:Zacks Industry Rank Analysis Highlights: Century Aluminum, Cigna, Dynamic Materials and MetLife.
Topics:



Related Articles
CombiMatrix Enters into Agreement to Acquire 33% of Oncology Drug Developer Leuchemix, Inc.; Company Continues Expansion in Drug Development Arena.
CombiMatrix Announces Availability of Comprehensive Influenza Array and Service; Array Can Identify All Strains of Influenza A, Including The H5N1...
CombiMatrix Molecular Diagnostics to Test for Influenza; Service Will Enable Identification of (H5N1) Bird Flu.
CombiMatrix Expands Catalog Microarray Product Line By Launching microRNA arrays.
CombiMatrix Launches Next Generation of Its Influenza A Surveillance Technology; 4X2K(TM) Format for All Strains of Influenza A, Including the H5N1...
CombiMatrix to Collaborate with the Washington Animal Disease Diagnostic Laboratory (WADDL) on USA's National Early Detection System for Avian...
CombiMatrix Advances Capability of Influenza Array; Protocols for Identifying Drug Resistance Are Being Developed.
CombiMatrix Updates Influenza Array with New Flu Sequences from the Centers for Disease Control.
CombiMatrix Awarded New US Air Force Contract to Advance Influenza-Detection System.
CombiMatrix Updates Influenza-Detection System and Demonstrates Use.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles